title: CRISPR/Cas9: a double-edged sword when used to combat HIV infection.
authors.affiliation: McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T1E2, Canada. chen.liang@mcgill.ca.|Departments of Medicine, Microbiology and Immunology, McGill University, Montreal, QC, H3A 2B4, Canada. chen.liang@mcgill.ca.
authors.forename: Chen
authors.initials: C
authors.lastname: Liang
authors.affiliation: McGill University AIDS Centre, Lady Davis Institute, Jewish General Hospital, Montreal, QC, H3T1E2, Canada.|Departments of Medicine, Microbiology and Immunology, McGill University, Montreal, QC, H3A 2B4, Canada.
authors.forename: Mark A
authors.initials: MA
authors.lastname: Wainberg
authors.affiliation: Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
authors.forename: Atze T
authors.initials: AT
authors.lastname: Das
authors.affiliation: Laboratory of Experimental Virology, Department of Medical Microbiology, Center for Infection and Immunity Amsterdam (CINIMA), Academic Medical Center, University of Amsterdam, Meibergdreef 15, 1105 AZ, Amsterdam, The Netherlands.
authors.forename: Ben
authors.initials: B
authors.lastname: Berkhout
mesh_terms: D019380:Anti-HIV Agents / Q000378:metabolism / Q000494:pharmacology; D064113:CRISPR-Cas Systems / Q000235:genetics*; D024882:Drug Resistance, Viral; D015316:Genetic Therapy; D015658:HIV Infections / Q000235:genetics / Q000628:therapy*; D015497:HIV-1 / Q000235:genetics; D054643:INDEL Mutation; D008954:Models, Biological; D011533:Proviruses / Q000235:genetics / Q000378:metabolism; D017735:Virus Latency / Q000235:genetics
chemical_list: D019380:Anti-HIV Agents